scispace - formally typeset
R

Rachel Brown

Researcher at University College London

Publications -  17
Citations -  1005

Rachel Brown is an academic researcher from University College London. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 7, co-authored 12 publications receiving 581 citations. Previous affiliations of Rachel Brown include University College London Hospitals NHS Foundation Trust & UCL Institute of Neurology.

Papers
More filters
Journal ArticleDOI

The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings.

Ross W. Paterson, +74 more
- 01 Oct 2020 - 
TL;DR: A case series of 43 patients with neurological complications of SARS-CoV-2 infection includes encephalopathies, encephalitis, acute disseminated encephalomyelitis with haemorrhagic change, transverse myelitis, ischaemic stroke, and Guillain-Barré syndrome.
Journal ArticleDOI

Early detection of melanoma metastases with radioiodinated methylene blue

TL;DR: This first clinical investigation concerning the diagnostic potential of radioiodinated MTB in patients with disseminated melanoma confirmed the existence of approximately 80% of internal lesions previously identified by routine methods and enabled detection of unknown secondaries in 6 of 12 patients studied.
Journal ArticleDOI

Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes

TL;DR: This article found increased concentrations of neurofilament light, a dynamic biomarker of neuronal damage, in the CSF of patients with COVID-19 and characterized neurological syndromes involving the PNS and CNS.
Journal ArticleDOI

Mutation of TBCK causes a rare recessive developmental disorder.

TL;DR: All affected siblings share homozygosity for a novel 4-bp deletion in the gene TBCK, providing the genetic cause of a severe inherited disease in a family and extending the number of mutations and phenotypes associated with this recently identified disease gene.
Journal ArticleDOI

Amyloid processing in COVID‐19‐associated neurological syndromes

TL;DR: Altered amyloid processing was linked to neuronal injury and neuroinflammation but reduced astrocyte activation and a sensitivity analysis of COVID‐19‐associated GBS revealed a non‐significant trend toward greater impairment of amyloids processing in CO VID‐19 central than peripheral neurological syndromes.